Toggle navigation
Home
Solutions
By Disease
Acute Myeloid Leukemia (AML)
Acute Lymphocytic Leukemia (ALL)
Chronic Myeloid Leukemia (CML)
Chronic Lymphocytic Leukemia (CLL)
Acute Promyelocytic Leukemia (APL)
Adult T-cell Leukemia (ATL)
By Target
Protein Kinase Inhibitors Development Services
FLT3 Inhibitors Development Services
IDH Inhibitions Development Services
BCL-2 Inhibitors Development Services
BCR-ABL Inhibitors Development Services
BTK Inhibitors Development Services
PI3K Inhibitors Development Services
Immune Checkpoint Inhibitors Development Services
PD-L1 Inhibitors Development Services
PD-1 Inhibitors Development Services
CTLA-4 Inhibitors Development Services
Hypomethylating Agents Development Services
DNA Methyltransferase (DNMT)
Ten-eleven Translocation (TET)
Hedgehog Drug Development Services
HTLV-1 Drug Development Services
Transactivator From the X-gene Region (Tax)
HTLV-1 Basic Leucine-zipper Factor (HBZ)
BLV Drug Development Services
FeLV Drug Development Services
Cell Surface Antigen Drug Development Services
By Molecule Type
Small Molecule Drug Development Services
Small Molecule Drug Design Services
High-Throughput Drug Screening Services
Hit-to-Lead Services
Lead Optimization Services
Drug Resistance Services
Therapeutic Antibody Development for Leukemia
Monoclonal Antibody Development Services
Therapeutic Bispecific Antibodies Development Services
Therapeutic Trispecific Antibodies Development Services
Antibody-Drug Conjugates Development Services
Antigen Design Services
Antibody Discovery Services
Antibody Engineering and Optimization Services
Antibody Characterization Services
Cell Therapy Development for Leukemia
T Cell Immunotherapy Development Services
CAR T Cell Therapy Development for Leukemia
TCR-engineered T Cell Therapy Development for Leukemia
γδ T Cell Therapy Development for Leukemia
Natural Killer Cell Therapy Development Services
Cytokine-Induced Killer Cell Therapy Development Services
Stem Cell Transplant Development Services
Gene Therapy Development for Leukemia
Therapeutic Vaccines Development for Leukemia
Development of Peptide Vaccines for Leukemia
Dendritic Cell Vaccines Development for Leukemia
DNA Vaccines Development for Leukemia
Oncolytic Viral Therapy Development for Leukemia
Combination Therapies Development for Leukemia
By Research Phase
Diagnostic Development for Leukemia
Biomarker Discovery Services
Leukemia Immunophenotyping Services
MRD Detection Development Services
MRD Detection Development Services for AML
MRD Detection Development Services for ALL
MRD Detection Development Services for CML
MRD Detection Development Services for CLL
Leukemia Virus Detection Development Services
HTLV-1 Detection Development Services
Bovine Leukemia Virus Detection Development Services
Feline Leukemia Virus Detection Development Services
Avian Leukosis Virus Detection Development Services
Chromosomal Translocations Detection Development Services
Blood Testing Services
Leukemia Colony Forming Cell Assay Services
Experimental Pathology Services
Leukemia Model Development Services
Leukemia Cell Lines Custom Services
Custom 2D and 3D Cell Culture Models of Leukemia
Custom Animal Models of Leukemia
AML Models Development Services
CML Models Development Services
ALL Models Development Services
CLL Models Development Services
Therapy Development Services for Leukemia
Target Identification Services
Disease Genes Identification Services
Signaling Pathways Identification Services
Mechanism of Action Studies Services for Leukemia
Preclinical Services for Leukemia Therapy
Efficacy Evaluation Services
In Vitro
Pharmacology Services
In Vivo
Pharmacology Services
DMPK Services
Toxicology Services
About Us
Contact Us
Careers
×
Contact Us
Home
Contact Us
Contact Us
If you'd like to learn more about leukemia, please email or call us.
Get in touch
Name
Email
*
Phone
*
Services Interested
*
Project Description
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
SUBMIT